Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration
- PMID: 15274117
- DOI: 10.1002/pmic.200300822
Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration
Abstract
Only few biological markers are currently available for the routine diagnosis of brain damage-related disorders including cerebrovascular, dementia, and other neurodegenerative diseases. In this study, post-mortem cerebrospinal fluid samples were used as a model of massive brain insult to identify new markers potentially relevant for neurodegeneration. The protein pattern of this sample was compared to the one of cerebrospinal fluid from healthy subjects by two-dimensional gel electrophoresis. Using gel imaging, N-terminal microsequencing, mass spectrometry, and immunodetection techniques, we identified 13 differentially expressed proteins. Most of these proteins have been previously reported to be somehow associated with brain destruction or with the molecular mechanisms underlying certain neurodegenerative conditions. These data indicate that the identified proteins indeed represent potential biomarkers of brain damage. We recently showed that H-FABP, a protein highly homologous to E-FABP and A-FABP identified in this study, is a potential marker of Creutzfeldt-Jakob disease and stroke.
Similar articles
-
Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid.J Proteome Res. 2006 Jul;5(7):1674-81. doi: 10.1021/pr060160v. J Proteome Res. 2006. PMID: 16823975
-
The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.N Engl J Med. 1996 Sep 26;335(13):924-30. doi: 10.1056/NEJM199609263351303. N Engl J Med. 1996. PMID: 8782499
-
The quest for brain disorder biomarkers.J Med Invest. 2005 Nov;52 Suppl:231-5. doi: 10.2152/jmi.52.231. J Med Invest. 2005. PMID: 16366504
-
CSF proteome: a protein repository for potential biomarker identification.Expert Rev Proteomics. 2005 Jan;2(1):57-70. doi: 10.1586/14789450.2.1.57. Expert Rev Proteomics. 2005. PMID: 15966853 Review.
-
Analysis of cerebrospinal fluid proteins by electrophoresis.J Chromatogr. 1991 Sep 13;569(1-2):281-96. doi: 10.1016/0378-4347(91)80234-4. J Chromatogr. 1991. PMID: 1939490 Review.
Cited by
-
The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients.Clin Chem. 2008 Oct;54(10):1617-23. doi: 10.1373/clinchem.2008.104497. Epub 2008 Aug 14. Clin Chem. 2008. PMID: 18703769 Free PMC article.
-
H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.PLoS One. 2017 Apr 18;12(4):e0175572. doi: 10.1371/journal.pone.0175572. eCollection 2017. PLoS One. 2017. PMID: 28419114 Free PMC article.
-
What Room for Two-Dimensional Gel-Based Proteomics in a Shotgun Proteomics World?Proteomes. 2020 Aug 6;8(3):17. doi: 10.3390/proteomes8030017. Proteomes. 2020. PMID: 32781532 Free PMC article. Review.
-
Two-dimensional protein electrophoresis: from molecular pathway discovery to biomarker discovery in neurological disorders.NeuroRx. 2006 Jul;3(3):327-35. doi: 10.1016/j.nurx.2006.05.001. NeuroRx. 2006. PMID: 16815216 Free PMC article. Review.
-
Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review.Int J Mol Sci. 2023 Jul 5;24(13):11130. doi: 10.3390/ijms241311130. Int J Mol Sci. 2023. PMID: 37446307 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
